Preterm birth
Conditions
Interventions
Group 2:Atosiban
Group 1:Nifedipine
Sponsors
West China second hospital, Sichuan university
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Woman who have threatened preterm birth and are treated with pharmacologic treatment; 2. Regular antenatal cares; 3. Agree to participate in the trial and sign informed consent; 4. Attend follow-up until the end of pregnancy.
Exclusion criteria
Exclusion criteria: 1. fetal chromosomal abnormalities or congenital developmental malformations, etc; 2. Pregnant women who have communication barriers; 3. Refused to participate; 4. Those who do not meet the entry criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of preterm birth;Days of pregnancy extension;Time of hospitalization; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse pregnant events;Neonatal mortality;Adverse neonatal outcome;Incidence of postpartum hemorrhage; | — |
Countries
China
Contacts
Public ContactShu Zhou
West China Second University Hospital
Outcome results
None listed